Genomic Analysis: Steering Clinical Trials

The Scientist is bringing together a panel of experts to discuss the current state and future direction of genomic analysis in oncology clinical trials.

Sep 11, 2019
The Scientist Creative Services Team

FREE Webinar

Friday, October 25, 2019
2:30 - 4:00 PM Eastern Time

Register Now

Genotyping during the active study phase of clinical trials is becoming more popular because of lower costs and the availability of high-throughput microarray platforms that quickly provide accurate results. During oncology clinical trials, genomics data enable better patient stratification, optimized study results, and well-planned study designs. In this webinar brought to you by The Scientist, our panel of experts will discuss the current state and future direction of genomic analysis in oncology clinical trials.

Topics to be Covered:

  • Pros and cons of biomarker-based patient selection versus biomarker discovery in clinical trials
  • Breast cancer precision medicine: the right drug for the right patient at the right time

Register Now

Meet the Speakers:

Lajos Pusztai, MD, DPhil
Professor of Medicine (Medical Oncology)
Breast Medical Oncology Group
Yale School of Medicine


Laura J. van 't Veer, PhD
Leader, Breast Oncology Program
Director, Applied Genomics
UCSF Helen Diller Family Comprehensive Cancer Center
Angela and Shu Kai Chan Endowed Chair in Cancer Research